Clinical and Diagnostic Laboratory Immunology, May 1999, p. 345-351, Vol. 6, No. 3
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
MRC AIDS Virus Research Unit, National Institute for Virology, and Department of Virology, University of the Witwatersrand, Johannesburg, South Africa
Received 7 October 1998/Returned for modification 18 November 1998/Accepted 26 January 1999
Degranulation of peripheral blood polymorphonuclear leukocytes
(PMNLs) was monitored in human immunodeficiency virus (HIV) type 1 (HIV-1)-infected individuals with or without pulmonary tuberculosis
(HIV/TB and HIV groups, respectively) by measuring the release of
-glucuronidase induced by interleukin-8 (IL-8). This was increased
in a dose-dependent manner in the control groups consisting of healthy
blood donors and patients with pulmonary tuberculosis. In contrast,
PMNLs from the HIV and HIV/TB groups responded reciprocally in the same
assay; that is, higher IL-8 input concentrations resulted in the
release of less enzyme than lower IL-8 input concentrations. The
degranulation response of PMNLs from HIV-1-infected individuals was
similarly altered for another agonist,
N-formyl-methionyl-leucyl-phenylalanine, suggesting that
impairment of the nonoxidative armature of PMNL was a more generalized
phenomenon. However, impaired IL-8-induced degranulation was found to
be associated with the reduced expression of both IL-8 receptors, A and
B, on whole-blood PMNLs from HIV-1-infected patients compared with that
on whole-blood PMNLs from healthy persons. The density of IL-8RA, in
particular, was most reduced on the surfaces of PMNLs from those
patients with the poorest degranulation in response to IL-8.
Inefficient agonist-induced degranulation may contribute to the
increased susceptibility of HIV-1-infected persons to secondary
microbial infections, this being further exacerbated in HIV/TB patients
who, in addition, display defects in phagocytosis and oxidative burst.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |